Stock & Company Details
Design Therapeutics Inc $DSGN
Price:
N/A
N/A
63M
$693M
52 Week High:
N/A
10 Day Average Volume:
N/A
-9.37
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DSGN technical indicators
Latest Design Therapeutics Inc (DSGN) indicator readings as of 2026-10-29.
DSGN's 14-day RSI is 46.3, in neutral territory. At $11.06 it is trading 9.1% below its 200-day moving average of $12.16, and below its 50-day average of $12.75. Price sits in the middle of its Bollinger Bands ($9.45 to $12.46). ADX reads 24.0, sitting between trending and range-bound.
Overview
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.
Finance Bot
Ask your questions
Start by typing a question below.
